Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.

[1]  D. Candinas,et al.  Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival. , 2020, Surgery.

[2]  D. Candinas,et al.  Minimal-Invasive Versus Open Hepatectomy for Colorectal Liver Metastases: Bicentric Analysis of Postoperative Outcomes and Long-Term Survival Using Propensity Score Matching Analysis , 2020, Journal of clinical medicine.

[3]  S. Truant,et al.  First Long-term Oncologic Results of the ALPPS Procedure in a Large Cohort of Patients With Colorectal Liver Metastases. , 2020, Annals of surgery.

[4]  T. Pawlik,et al.  Parenchyma-sparing liver resections. , 2020, International journal of surgery.

[5]  Jeffrey E. Lee,et al.  Anatomic Resection Is Not Required for Colorectal Liver Metastases with RAS Mutation , 2020, Journal of Gastrointestinal Surgery.

[6]  T. Hickish,et al.  Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial , 2020, The Lancet. Oncology.

[7]  M. Beaussier,et al.  Laparoscopic Parenchymal-Sparing Hepatectomy for Multiple Colorectal Liver Metastases Improves Outcomes and Salvageability: A Propensity Score-Matched Analysis , 2019, Annals of Surgical Oncology.

[8]  Zhe-yu Chen,et al.  Parenchymal‐sparing versus extended hepatectomy for colorectal liver metastases: A systematic review and meta‐analysis , 2019, Cancer medicine.

[9]  F. Fujita,et al.  Sinusoidal Obstruction Syndrome and Postoperative Complications Resulting from Preoperative Chemotherapy for Colorectal Cancer Liver Metastasis , 2019, AntiCancer Research.

[10]  B. Edwin,et al.  Laparoscopic Multiple Parenchyma-sparing Concomitant Liver Resections for Colorectal Liver Metastases , 2019, Surgical laparoscopy, endoscopy & percutaneous techniques.

[11]  I. Endo,et al.  Higher Tumor Burden Neutralizes Negative Margin Status in Hepatectomy for Colorectal Cancer Liver Metastasis , 2018, Annals of Surgical Oncology.

[12]  Andrew J. Lee,et al.  Intrahepatic Recurrence Patterns Predict Survival After Resection of Colorectal Liver Metastases , 2018, Annals of Surgical Oncology.

[13]  Sheraz Yaqub,et al.  Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled Trial , 2018, Annals of surgery.

[14]  L. Spelt,et al.  Parenchyma-sparing hepatectomy (PSH) versus non-PSH for bilobar liver metastases of colorectal cancer , 2017, Annals of gastroenterology.

[15]  G. Wakabayashi,et al.  The Southampton Consensus Guidelines for Laparoscopic Liver Surgery: From Indication to Implementation , 2017, Annals of surgery.

[16]  I. Endo,et al.  The Tumor Burden Score: A New “Metro-ticket” Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors , 2018, Annals of surgery.

[17]  Jeffrey E. Lee,et al.  Operative and short-term oncologic outcomes of laparoscopic versus open liver resection for colorectal liver metastases located in the posterosuperior liver: a propensity score matching analysis , 2018, Surgical Endoscopy.

[18]  U. Neumann,et al.  Risk Adjustment in ALPPS Is Associated With a Dramatic Decrease in Early Mortality and Morbidity , 2017, Annals of surgery.

[19]  G. Torzilli,et al.  Parenchymal-Sparing Surgery for the Surgical Treatment of Multiple Colorectal Liver Metastases Is a Safer Approach than Major Hepatectomy Not Impairing Patients' Prognosis: A Bi-Institutional Propensity Score-Matched Analysis , 2017, Digestive Surgery.

[20]  M. Choti,et al.  Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases , 2017, Annals of surgery.

[21]  G. Poston,et al.  Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[22]  M. Schmelzle,et al.  Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[23]  T. Pawlik,et al.  Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review , 2017, Journal of Gastrointestinal Surgery.

[24]  T. Ishizawa,et al.  Parenchymal-sparing hepatectomy for deep-placed colorectal liver metastases. , 2016, Surgery.

[25]  M. Schmelzle,et al.  [The Impact of Tumor Cell Proliferation on Occult Micrometastases, Tumor Recurrence and Patient Outcome Following Resection for Liver Malignancies]. , 2016, Zentralblatt fur Chirurgie.

[26]  J. Vauthey,et al.  Parenchymal-sparing Hepatectomy in Colorectal Liver Metastasis Improves Salvageability and Survival. , 2016, Annals of surgery.

[27]  T. Gruenberger,et al.  Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  F. Tomassini,et al.  Impact of surgical margins on overall and recurrence-free survival in parenchymal-sparing laparoscopic liver resections of colorectal metastases , 2015, Surgical Endoscopy.

[29]  J. Vauthey,et al.  Is Complete Liver Resection Without Resection of Synchronous Lung Metastases Justified? , 2015, Annals of Surgical Oncology.

[30]  F. Giuliante,et al.  Early Recurrence After Liver Resection for Colorectal Metastases: Risk Factors, Prognosis, and Treatment. A LiverMetSurvey-Based Study of 6,025 Patients , 2014, Annals of Surgical Oncology.

[31]  J. Shindoh,et al.  Portal vein embolization improves rate of resection of extensive colorectal liver metastases without worsening survival , 2013, The British journal of surgery.

[32]  Steven A. Curley,et al.  RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for Colorectal Liver Metastases , 2013, Annals of surgery.

[33]  S. Curley,et al.  Margin Status Remains an Important Determinant of Survival After Surgical Resection of Colorectal Liver Metastases in the Era of Modern Chemotherapy , 2013, Annals of surgery.

[34]  J. Shindoh,et al.  Optimal Future Liver Remnant in Patients Treated with Extensive Preoperative Chemotherapy for Colorectal Liver Metastases , 2013, Annals of Surgical Oncology.

[35]  P. Bachellier,et al.  Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. , 2012, Annals of surgery.

[36]  S. Curley,et al.  Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate. , 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[37]  S. Curley,et al.  High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  J. Ijzermans,et al.  Anatomical Versus Nonanatomical Resection of Colorectal Liver Metastases: Is There a Difference in Surgical and Oncological Outcome? , 2010, World Journal of Surgery.

[39]  M. Makuuchi,et al.  The Clavien-Dindo Classification of Surgical Complications: Five-Year Experience , 2009, Annals of surgery.

[40]  G. Torzilli,et al.  One-stage ultrasonographically guided hepatectomy for multiple bilobar colorectal metastases: a feasible and effective alternative to the 2-stage approach. , 2009, Surgery.

[41]  Mithat Gönen,et al.  Increased Use of Parenchymal-Sparing Surgery for Bilateral Liver Metastases From Colorectal Cancer Is Associated With Improved Mortality Without Change in Oncologic Outcome: Trends in Treatment Over Time in 440 Patients , 2008, Annals of surgery.

[42]  S. Curley,et al.  Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. , 2007, Journal of the American College of Surgeons.

[43]  O. Garden,et al.  Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies , 2006, British Journal of Cancer.

[44]  S. Strasberg,et al.  Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. , 2005, Journal of hepato-biliary-pancreatic surgery.

[45]  Kenneth Hess,et al.  Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases , 2004, Annals of surgery.